Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial
Hyo‐Soo Kim, Jeehoon Kang, Doyeon Hwang, Jung‐Kyu Han, Han‐Mo Yang, Hyun‐Jae Kang, Bon‐Kwon Koo, Jay Young Rhew, Kook Jin Chun, Young‐Hyo Lim, Jung Min Bong, Jang‐Whan Bae, Bong Ki Lee, Kyung Woo Park
Topics & Concepts
MedicinePrasugrelAcute coronary syndromePercutaneous coronary interventionInternal medicineClinical endpointMyocardial infarctionConventional PCIAspirinRandomized controlled trialCardiologyAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes